Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851615 · ClinicalTrials.gov registry record · NA
Improving Self-Management in Adolescents With Sickle Cell Disease
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT02851615 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 66 participants.
The verdict
NCT02851615, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The objective of this study is to determine the feasibility and acceptability of SCThrive, a an innovative, technology-enhanced, group self-management intervention that uses a mixed in-person and online format and supported by a tailored mHealth tool, iManage. The study will also evaluate the initial efficacy of SCThrive for increasing behavioral activation (BA) in adolescents with Sickle Cell Disease (SCD) ages 13 to 21. The investigators hypothesize that participants in the SCThrive group will show greater BA (primary outcome) at post-treatment than the attention control group, and that participants in the SCThrive group will continue to show significantly greater BA at the six week follow-up compared to the attention control group. Investigators will also explore whether SCThrive is associated with greater improvements in self-management behaviors and quality of life (secondary outcome) compared to attention control at the six-week follow-up assessment.
Interventions
- BEHAVIORAL SCThrive Intervention for Adolescents with SCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-03-31 |
| Est. Completion | 2018-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02851615
The ClinicalTrials.gov registry entry for NCT02851615 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SCThrive Intervention for Adolescents with SCD is the first listed.
NCT02851615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02851615 about?
NCT02851615 is a clinical study titled "Improving Self-Management in Adolescents With Sickle Cell Disease". The objective of this study is to determine the feasibility and acceptability of SCThrive, a an innovative, technology-enhanced, group self-management intervention that uses a mixed in-person and online format and supported by a tailored mHealth tool, iManage. The study will also evaluate the initia...
What is the current status of trial NCT02851615?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2016-03-31. Estimated completion is 2018-03-31.
What interventions are being tested in trial NCT02851615?
The interventions under investigation include: SCThrive Intervention for Adolescents with SCD (BEHAVIORAL).
Who is sponsoring clinical trial NCT02851615?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.